Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FRUTI: Furazidin vs Nitrofurantoin in uncomplicated lower urinary tract infections
2020-005559-19Phase 3Completed
- Sponsor
- Adamed Pharma
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of furazidin in urinary tract infection (UTI) (2 arms), sponsored by Adamed Pharma. Primary endpoint: Primary composite efficacy endpoint. Started Jan 2021; status: completed.
02
Drugs
furazidin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on 2020-005559-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005559-19.